NCT02900755View on ClinicalTrials.gov

Effects of Perampanel on Cognition and Electroencephalography in Patients With Epilepsy

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

April 30, 2019

Study Completion Date

November 20, 2020

Conditions
Electroencephalography
Interventions
DRUG

Perampanel

The subjects will be administered oral perampanel for six months. Dose will be titrated according to the tolerance and be maintained at least 1 month before second EEG evaluation.

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT02900755 - Effects of Perampanel on Cognition and Electroencephalography in Patients With Epilepsy | Biotech Hunter | Biotech Hunter